Global Biosimilars Market 2014-2018 - Market Trends, Size, Analysis and Forecast - PowerPoint PPT Presentation

About This Presentation
Title:

Global Biosimilars Market 2014-2018 - Market Trends, Size, Analysis and Forecast

Description:

Big Market Research present “Global Biosimilars Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2018. Visit for more info @ The Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing. – PowerPoint PPT presentation

Number of Views:90

less

Transcript and Presenter's Notes

Title: Global Biosimilars Market 2014-2018 - Market Trends, Size, Analysis and Forecast


1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Biosimilars Market 2014-2018 Growth,
Global Share, Industry Overview, Analysis, Trends
Opportunities and Forecast
2
Description
Report Overview
The Global Biosimilars Market to grow at a CAGR
of 27.58 percent over the period 2013-2018. One
of the key factors contributing to this market
growth is the increasing number of patent
expirations. The Global Biosimilars Market has
also been witnessing the outsourcing of
biosimilar manufacturing. However, the risks
related to drug failure could pose a challenge to
the growth of this market. The Global Biosimilars
Market 2014-2018, has been prepared based on an
in-depth market analysis with inputs from
industry experts. The report covers Americas,
EMEA and APAC regions it also covers the Global
Biosimilars market landscape and its growth
prospects in the coming years.   Read more
details at http//www.bigmarketresearch.com/globa
l-biosimilars-2014-2018-market
3
Description
Report Overview
 The report also includes a discussion of the key
vendors operating in this market.   Key vendors
dominating this space include Biocon Ltd.,
Hospira Inc., Mylan Inc., Novartis AG, Teva
Pharmaceutical Industries Ltd., Intas
Pharmaceuticals Ltd., Dr. Reddy's Laboratories
Ltd., F. Hoffmann-La Roche Ltd., 3SBio Inc., and
Celltrion Inc. Other vendors mentioned in the
report are Actavis plc, Amgen Inc., AstraZeneca
plc, Baxter International Inc., Biogen Idec Inc.,
Bioton S.A., Boehringer Ingelheim GmbH, Cipla
Ltd., Coherus Biosciences Inc., Daiichi Sankyo
Co. Ltd., Emcure Pharmaceuticals Ltd., GE
Healthcare Ltd., GeneScience Pharmaceuticals Co.
Ltd., GlaxoSmithKline plc, JCR Pharmaceuticals
Co. Ltd., iBio Inc., LG Life Sciences Co. Ltd.,
Merck Co. Inc., Pfizer Inc., Ranbaxy
Laboratories Ltd., Samsung Biologics Co. Ltd.,
Sanofi S.A., and Wockhardt Ltd.
4
Table Of Contents
Table of Contents 01. Executive Summary 02. List
of Abbreviations 03. Scope of the Report 04.
Market Research Methodology 05. Introduction 06.
Market Landscape 07. Market Segmentation by
Application 08. Geographical Segmentation 09.
Buying Criteria 10. Market Growth Drivers
5
Key Audiences
Key questions answered in this report What will
the market size be in 2016/2018 and what will be
the growth rate? What are key market trends? What
is driving this market? What are the challenges
to market growth? Who are the key vendors in this
market space? What are the market opportunities
and threats faced by key vendors? What are the
strengths and weaknesses of each of these key
vendors?   Enquire about report
http//www.bigmarketresearch.com/report-enquiry/17
682
6
Get Full Information At http//www.bigmarketrese
arch.com/global-biosimilars-2014-2018-market
Write a Comment
User Comments (0)
About PowerShow.com